The latest update on gov.ie puts public health policy back in the spotlight, as Ireland opens a new opportunity for people to influence how screening services develop in the years ahead. The Department of Health has confirmed that the 2026 National Screening Advisory Committee process is now open, inviting submissions from the public, clinicians, advocacy groups, and other stakeholders.
This new gov.ie announcement matters because screening programmes shape early detection, prevention, and treatment outcomes across the health system. With support from the Department of Health and the wider Health Service Executive (HSE), the National Screening Advisory Committee, or NSAC, reviews proposals for new population-based screening programmes and changes to existing ones.
Why the gov.ie screening announcement matters
According to gov.ie, the committee plays an independent advisory role for the Minister for Health. Its recommendations help guide decisions in Health policy, particularly where evidence, cost-effectiveness, and population benefit must be carefully balanced.
Minister for Health Jennifer Carroll MacNeill said the call for submissions gives people a real chance to help shape the future of screening in Ireland. That point is significant: previous submissions helped inform the addition of screening for Severe Combined Immunodeficiency and Spinal Muscular Atrophy, showing that the process can lead to meaningful change.
The current call will remain open for 12 weeks and closes at 5:00pm on Friday, 28 August 2026. Full submission details are available through the NSAC portal linked from gov.ie.
Current population screening programmes in Ireland
Ireland currently operates six major programmes that support preventative healthcare and earlier diagnosis:
- National Newborn Bloodspot Screening Programme
- Universal Newborn Hearing Screening Programme
- BreastCheck
- CervicalCheck
- BowelScreen
- Diabetic RetinaScreen
These services sit within a broader public service framework that includes the Department of the Taoiseach, Public Expenditure, Finance, and agencies such as the Health Service Executive (HSE) and HIQA, all of which influence healthcare delivery, standards, oversight, or resource planning.
Read more: Explore more Irish public service updates
How the gov.ie submission process works
The gov.ie notice makes clear that submissions are not limited to medical professionals. Members of the public, organisations, patient advocates, and researchers can all contribute ideas, evidence, and lived experience. That inclusive approach reflects a wider trend across Irish public bodies, from the Workplace Relations Commission (WRC) to the Data Protection Commission (DPC), where stakeholder input increasingly shapes policy design.
NSAC was established in 2019 following recommendations made in Dr Gabriel Scally’s review of CervicalCheck. Since then, it has acted as an expert channel for examining whether screening proposals meet the threshold for public health benefit, safety, and practical delivery.
What contributors should keep in mind
- Proposals should be evidence-based where possible.
- Submissions can address new screening programmes or changes to existing ones.
- Patient experience and service access may help inform priorities.
- Closing dates matter, and late submissions may not be considered.
Explore: Latest policy and health coverage from Ireland
What this means for Irish healthcare policy
This gov.ie update is more than a routine press release. It signals how Ireland continues to connect public consultation with preventative care strategy. In a policy environment where Health, Social Protection, Education, and Local Government often overlap, screening decisions can have long-term effects on care pathways, waiting lists, and health outcomes.
For readers who want a practical takeaway, the message is simple: the 2026 NSAC call gives the public a direct route into the conversation about future screening services. As gov.ie highlights, submissions can influence priorities, and in some cases, they can shape the next generation of screening in Ireland.
Read more: Explore broader news and analysis
